TRIM71
protein-codingtripartite motif containing 71, the group of Tripartite motif family|Ring finger proteins
Gene summary
The protein encoded by this gene is an E3 ubiquitin-protein ligase that binds with miRNAs and maintains the growth and upkeep of embryonic stem cells. This gene also is involved in the G1-S phase transition of the cell cycle. [provided by RefSeq, Dec 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~79.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032862
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0032862
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032862
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032862
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0032862
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TRIM71 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001039111.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 32 | 1 | 33 | |||
| missense | 2 | 4 | 138 | 11 | 155 | |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 3 | 5 | ||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 4 | 5 | 141 | 43 | 1 | 194 |
Highest pathogenic variant AF is 6.852873e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001034200.1 | 4 | MANE Select | |
| Ensembl | ENSP00000373272.3 | 4 | MANE Select | |
| Ensembl | ENSP00000588304.1 | 4 | Standard | |
| Ensembl | ENSP00000588304.1 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| trim71 | Danio rerio | Structure: post-vent region Quality: sigmoid abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- MicroRNAs in cancer - Homo sapiens (human)
- Mesodermal Commitment Pathway
- let-7 inhibition of ES cell reprogramming
- Immune System
- Adaptive Immune System
Biological Process
- G1/S transition of mitotic cell cycle
- protein polyubiquitination
- neural tube closure
- fibroblast growth factor receptor signaling pathway
- miRNA metabolic process
Molecular Function
- ubiquitin-protein transferase activity
- protein binding
- zinc ion binding
- translation repressor activity
- miRNA binding
Cellular Component
- P-body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000383763
- Coding exons
- 4
- Length
- 79809
- Individuals with no LoFs
- 112519
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 112520
- p
- 0.00000444
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.28 | 295 | 502 | 0.588 | 0.0000305 | 5581 |
| Missense (PolyPhen) | 31 | 158.33 | 0.1958 | 1537 | ||
| Synonymous | -3.53 | 294 | 226 | 1.30 | 0.0000142 | 1867 |
| Loss of Function | 4.69 | 1 | 27.6 | 0.0363 | 0.00000164 | 265 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000010 | 0.000010 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that cooperates with the microRNAs (miRNAs) machinery and promotes embryonic stem cells proliferation and maintenance (Probable). Binds to miRNAs and associates with AGO2, participating in post-transcriptional repression of transcripts such as CDKN1A (By similarity). In addition, participates in post-transcriptional mRNA repression in a miRNA independent mechanism (PubMed:23125361). Facilitates the G1-S transition to promote rapid embryonic stem cell self-renewal by repressing CDKN1A expression. Required to maintain proliferation and prevent premature differentiation of neural progenitor cells during early neural development: positively regulates FGF signaling by controlling the stability of SHCBP1 (By similarity). Specific regulator of miRNA biogenesis. Binds to miRNA MIR29A hairpin and postranscriptionally modulates MIR29A levels, which indirectly regulates TET proteins expression (PubMed:28431233). {ECO:0000250|UniProtKB:Q1PSW8, ECO:0000269|PubMed:23125361, ECO:0000269|PubMed:28431233, ECO:0000305|PubMed:24239284}.;
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- LoFtool
- 0.00448
- RVIS EVS
- -1.13
- RVIS percentile EVS
- 6.43
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.512
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |